Reduction in Use of Risperidone for Dementia in Australia Following Changed Guidelines

• Main Authors: Lisa M Kalisch Ellett (Author), Anna K Moffat (Author), Svetla Gadzhanova (Author), Nicole L Pratt (Author), Jemisha Apajee (Author), Michael Woodward (Author), Elizabeth E Roughead (Author)
• Format: Book
• Published: MDPI AG, 2019-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

<b>Background:</b> Risperidone is the only antipsychotic approved in Australia for the management of the behavioural and psychological symptoms of dementia (BPSD). In June 2015, the Australian Government Therapeutic Goods Administration (TGA) amended the indication to restrict use in BPS...